image
IN8bio, Inc. INAB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.21
-1.96 %
$ 291 M
Market Cap
-0.27
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
24.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets IN8bio, Inc.
image
INAB has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart INAB

image
$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart INAB

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart INAB

image
$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)20232023202420242025202520262026202720272028202820292029